Search International and National Patent Collections

1. (WO2013125543) HETEROCYCLIC COMPOUND

Pub. No.:    WO/2013/125543    International Application No.:    PCT/JP2013/054054
Publication Date: Fri Aug 30 01:59:59 CEST 2013 International Filing Date: Wed Feb 20 00:59:59 CET 2013
IPC: C07D 471/04
A61K 31/437
A61K 31/444
A61K 31/496
A61K 31/497
A61K 31/506
A61P 1/04
A61P 17/00
A61P 17/06
A61P 19/02
A61P 25/00
A61P 29/00
A61P 37/02
A61P 37/06
A61P 43/00
Applicants: TAKEDA PHARMACEUTICAL COMPANY LIMITED
武田薬品工業株式会社
Inventors: NAGAMIYA, Hiroyuki
永宮 裕之
YOSHIDA, Masato
吉田 雅都
SETO, Masaki
瀬戸 雅樹
MARUI, Shogo
圓井 省吾
ODA, Tsuneo
小田 恒夫
ISHICHI, Yuji
石地 雄二
SUZUKI, Hideo
鈴木 英夫
KUSUMOTO, Tomokazu
楠本 友和
YOGO, Takatoshi
余郷 能紀
RHIM, Chul Yun
リム チュルヨン
YOON, Cheolhwan
ユン チョルファン
LEE, Gil Nam
イ ギルナム
KANG, Hyun Bin
カン ヒョンビン
KIM, Kwang Ok
キム クワンオク
JEON, Hye Sun
ジョン ヘソン
Title: HETEROCYCLIC COMPOUND
Abstract:
Provided is a prophylactic or therapeutic agent for autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus), which has an excellent Tyk2 inhibition activity. The present invention relates to a compound represented by formula (I) [wherein each symbol is as defined in the description attached] or a salt thereof.